We already have a deal with Vitrolife. But due to their lagging on the whole matter we have been forced to go with others in other markets. This may well send a clear signal to Vitrolife that their market is starting to shrink.
Re the other 2, yes they are testing the Felix already released in market Ann. Their offer will be, wanna take that through the process? Okay great, give us X amount $$ and x% of royalties, see you when it's commercial.
Once we get a few of those we can forget Felix and concentrate of the roXsta and other potential revenue makers.
MEM Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)